In a report released yesterday, Michael Graham from Canaccord Genuity maintained a Buy rating on Trupanion (NYSE: TRUP), with a price target of $40. The company’s shares opened today at $26.55.
According to TipRanks.com, Graham is a 5-star analyst with an average return of 15.4% and a 60.7% success rate. Graham covers the Technology sector, focusing on stocks such as The Meet Group Inc, Paypal Holdings, and Facebook Inc.
Trupanion has an analyst consensus of Strong Buy, with a price target consensus of $37.75.
Find more picks by Best Performing Analysts >>
The company has a one-year high of $37.13 and a one-year low of $15.66. Currently, Trupanion has an average volume of 412K.
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business segments. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance.
